Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013 (2013), Article ID 903234, 7 pages
http://dx.doi.org/10.1155/2013/903234
Research Article

Efficiency of pH-Sensitive Fusogenic Polymer-Modified Liposomes as a Vaccine Carrier

1Division of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, Izumisano, Osaka 598-8531, Japan
2Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, Sakai, Osaka 599-8531, Japan

Received 11 December 2012; Accepted 30 December 2012

Academic Editors: A. Shikanov, Y.-C. Tyan, and M.-H. Yang

Copyright © 2013 Shinobu Watarai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Krishman and T. R. Mosmann, “Functional subpopulation of CD4+ T lymphocytes,” in T Lymphocyte Subpopulation in Immunotoxicology, pp. 7–32, John Wiley & Sons, Chichester, UK, 1998. View at Google Scholar
  2. T. R. Mosmann and S. Sad, “The expanding universe of T-cell subsets: Th1, Th2 and more,” Immunology Today, vol. 17, no. 3, pp. 138–146, 1996. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Gregoriadis, “Immunological adjuvants: a role for liposomes,” Immunology Today, vol. 11, no. 3, pp. 89–97, 1990. View at Google Scholar · View at Scopus
  4. E. L. Romero and M. J. Morilla, “Topical and mucosal liposomes for vaccine delivery,” Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 3, no. 4, pp. 356–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. R. L. Gregory, S. M. Michalek, G. Richardson, C. Harmon, T. Hilton, and J. R. McGhee, “Characterization of immune response to oral administration of Streptococcus sobrinus ribosomal preparations in liposomes,” Infection and Immunity, vol. 54, no. 3, pp. 780–786, 1986. View at Google Scholar · View at Scopus
  6. L. P. Kahl, R. Lelchuk, C. A. Scott, and J. Beesley, “Characterization of Leishmania major antigen-liposomes that protect BALB/c mice against cutaneous leishmaniasis,” Infection and Immunity, vol. 58, no. 10, pp. 3233–3241, 1990. View at Google Scholar · View at Scopus
  7. R. Bülow and J. C. Boothroyd, “Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes,” Journal of Immunology, vol. 147, no. 10, pp. 3496–3500, 1991. View at Google Scholar · View at Scopus
  8. W. Li, S. Watarai, T. Iwasaki, and H. Kodama, “Suppression of Salmonella enterica serovar Enteritidis excretion by intraocular vaccination with fimbriae proteins incorporated in liposomes,” Developmental and Comparative Immunology, vol. 28, no. 1, pp. 29–38, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Irie, S. Watarai, T. Iwasaki, and H. Kodama, “Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes,” Fish and Shellfish Immunology, vol. 18, no. 3, pp. 235–242, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Rhalem, C. Bourdieu, G. Luffau, and P. Pery, “Vaccination of mice with liposome-entrapped adult antigens of Nippostrongylus brasiliensis,” Annales de l'Institut Pasteur. Immunology, vol. 139, no. 2, pp. 157–166, 1988. View at Google Scholar · View at Scopus
  11. D. T. O’Hagan and R. Rappuoli, “Novel approaches to vaccine delivery,” Pharmaceutical Research, vol. 21, no. 9, pp. 1519–1530, 2004. View at Google Scholar
  12. G. F. A. Kersten and D. J. A. Crommelin, “Liposomes and ISCOMs,” Vaccine, vol. 21, no. 9-10, pp. 915–920, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Gregoriadis, A. Bacon, W. Caparros-Wanderley, and B. McCormack, “A role for liposomes in genetic vaccination,” Vaccine, vol. 20, supplement 5, pp. B1–B9, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Christensen, K. S. Korsholm, P. Andersen, and E. M. Agger, “Cationic liposomes as vaccine adjuvants,” Expert Review of Vaccines, vol. 10, no. 4, pp. 513–521, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Akagi, X. Wang, T. Uto, M. Baba, and M. Akashi, “Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives,” Biomaterials, vol. 28, no. 23, pp. 3427–3436, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Yoshikawa, N. Okada, A. Oda et al., “Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier,” Biochemical and Biophysical Research Communications, vol. 366, no. 2, pp. 408–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. J. Kwon, S. M. Standley, S. L. Goh, and J. M. J. Fréchet, “Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles,” Journal of Controlled Release, vol. 105, no. 3, pp. 199–212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Kunisawa, T. Nakanishi, I. Takahashi et al., “Sendai virus fusion protein-mediates simultaneous induction of MHC class I/II-dependent mucosal and systemic immune responses via the nasopharyngeal-associated lymphoreticular tissue immune system,” Journal of Immunology, vol. 167, no. 3, pp. 1406–1412, 2001. View at Google Scholar · View at Scopus
  19. L. Bungener, K. Serre, L. Bijl et al., “Virosome-mediated delivery of protein antigens to dendritic cells,” Vaccine, vol. 20, no. 17-18, pp. 2287–2295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Yuba, C. Kojima, A. Harada, Tana, S. Watarai, and K. Kono, “pH-sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity,” Biomaterials, vol. 31, no. 5, pp. 943–951, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Sakaguchi, C. Kojima, A. Harada, and K. Kono, “Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH,” Bioconjugate Chemistry, vol. 19, no. 5, pp. 1040–1048, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kono, K. I. Zenitani, and T. Takagishi, “Novel pH-sensitive liposomes: liposomes bearing a poly(ethylene glycol) derivative with carboxyl groups,” Biochimica et Biophysica Acta, vol. 1193, no. 1, pp. 1–9, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Watarai, Y. Kushi, R. Shigeto et al., “Production of monoclonal antibodies directed to Hanganutziu-Deicher active gangliosides, N-glycolylneuraminic acid-containing gangliosides,” Journal of Biochemistry, vol. 117, no. 5, pp. 1062–1069, 1995. View at Google Scholar · View at Scopus
  24. A. Mark, B. Björkstén, and M. Granström, “ImmunoglobulinEresponsesto diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines,” Vaccine, vol. 13, no. 7, pp. 669–673, 1995. View at Google Scholar
  25. H. Aggerbeck, J. Wantzin, and I. Heron, “Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations—III,” Vaccine, vol. 14, no. 13, pp. 1265–1272, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. H. D. Nothdurft, T. Jelinek, A. Marschang, H. Maiwald, A. Kapaun, and T. Löscher, “Adverse reactions to Japanese encephalitis vaccine in travellers,” Journal of Infection, vol. 32, no. 2, pp. 119–122, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. P. C. Doherty and A. Kelso, “Toward a broadly protective influenza vaccine,” Journal of Clinical Investigation, vol. 118, no. 10, pp. 3273–3275, 2008. View at Google Scholar
  28. A. J. McMichael and T. Hanke, “HIV vaccines 1983–2003,” Nature Medicine, vol. 9, no. 7, pp. 874–880, 2003. View at Google Scholar
  29. M. Chen, M. Sällberg, A. Sönnerborg et al., “Limited humoral immunity in hepatitis C virus infection,” Gastroenterology, vol. 116, no. 1, pp. 135–143, 1999. View at Google Scholar
  30. D. Yerly, D. Heckerman, T. M. Allen et al., “Increased cytotoxic T-lymphocyte epitope variant cross-recognition and functional avidity are associated with hepatitis C virus clearance,” Journal of Virology, vol. 82, no. 6, pp. 3147–3153, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Han, S. Watarai, K. Kobayashi, and T. Yasuda, “Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization,” Journal of Veterinary Medical Science, vol. 59, no. 12, pp. 1109–1114, 1997. View at Google Scholar · View at Scopus
  32. S. Watarai, M. Han, Tana, and H. Kodama, “Antibody response in the intestinal tract of mice orally immunized with antigen associated with liposomes,” Journal of Veterinary Medical Science, vol. 60, no. 9, pp. 1047–1050, 1998. View at Google Scholar · View at Scopus
  33. C. M. Snapper and J. J. Mond, “Towards a comprehensive view of immunoglobulin class switching,” Immunology Today, vol. 14, no. 1, pp. 15–17, 1993. View at Google Scholar · View at Scopus
  34. A. Casadevall, “Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle,” Infection and Immunity, vol. 71, no. 8, pp. 4225–4228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Casadevall and L. A. Pirofski, “A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens,” Advances in Immunology, vol. 91, pp. 1–44, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. E. de Gregorio, E. Tritto, and R. Rappuoli, “Alum adjuvanticity: unraveling a century old mystery,” European Journal of Immunology, vol. 38, no. 8, pp. 2068–2071, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. E. B. Lindblad, “Aluminium compounds for use in vaccines,” Immunology and Cell Biology, vol. 82, no. 5, pp. 497–505, 2004. View at Google Scholar
  38. A. M. Harandi, D. Medaglini, and R. J. Shattock, “Vaccine adjuvants: a priority for vaccine research,” Vaccine, vol. 28, no. 12, pp. 2363–2366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Hem and J. L. White, “Structure and properties of aluminum-containing adjuvants,” Pharmaceutical Biotechnology, vol. 6, pp. 249–276, 1995. View at Google Scholar